Xie T, Peng S, Liu S, Zheng M, et al. Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer. Mol Cancer 2024;23:30.
PMID: 38341586